NEW YORK (GenomeWeb News) – Hologic said today that Third Wave Technologies' shareholders have tendered approximately 45,225,950 shares, or around 92.1 percent of the company’s outstanding stock, as of the close of its initial offering period to acquire Third Wave, which expired last night.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.